Answers are grounded in this paper and cite their sources.
Immunoglobulin G4-related disease (IgG4-RD) is a chronic inflammatory and immune-mediated disorder characterized by progressive fibrosis, primarily affecting glandular tissue. While recognition of the disease has increased significantly in recent years, its underlying immunopathology does not fully overlap with traditional autoimmunity models and is still not fully understood. With aging, the immune system undergoes increasing changes such as decreased naive lymphocyte output, accumulation of memory and effector populations, persistent low-grade activation, and impaired immune responses. Several immunological features reported in IgG4-RD resemble alterations observed in aging immune systems, raising the possibility that age-related immune remodeling creates an immunological environment permissive for chronic inflammation and fibrosis. Expansion of plasmablasts, skewing toward T follicular helper type 2 responses, accumulation of cytotoxic CD4+ T cells, and persistence of regulatory cytokine–dominant immune responses collectively suggest a chronically activated but incompletely resolving immune state. Similar patterns have been described in immunosenescence and inflammaging, where chronic antigenic stimulation, impaired immune regulation, and progressive remodeling of adaptive immunity promote sustained low-grade inflammation and tissue injury. Recent studies further suggest that cellular senescence and senescence-associated tissue remodeling may contribute to fibrosis in IgG4-RD. In particular, type 2 cytokine signaling, mitochondrial dysfunction, and senescence-related pathways have been implicated in fibroinflammatory changes within affected tissues, raising the possibility that immune aging and tissue remodeling are biologically interconnected processes in this disease. At the same time, these observations should be interpreted cautiously. Current evidence does not support the view that IgG4-RD simply represents a manifestation of immune aging. Rather, aging-associated immune remodeling may create a permissive immunological background in which disease-specific humoral, cytotoxic, and profibrotic pathways become amplified. In this review, we discuss the potential links between immunosenescence, inflammaging, cellular senescence, humoral immune dysregulation, and fibroinflammation in IgG4-RD, and consider how these interactions may provide broader insight into chronic fibroinflammatory disease.
No takes yet. Share an insight, caveat, or question.
Tüzün et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: